Merck Can't Arbitrate Antitrust Suit Over Vaccine Bundles
Law360 (January 23, 2019, 9:22 PM EST) -- Merck Sharp & Dohme Corp. cannot force each individual in a proposed class action to arbitrate claims that its pediatric vaccine bundles with alleged artificially inflated price tags are anti-competitive, a Pennsylvania federal judge ruled Tuesday, finding that the plaintiffs never signed arbitration agreements.
U.S. District Judge J. Curtis Joyner found that just because Merck had contracts containing arbitration clauses with three physician buying groups doesn't mean the pediatric medical practices bringing the action were signatories to those contracts when they bought rotavirus vaccines bundled with other common childhood vaccines through those groups, according to the order filed Wednesday.
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!